CytomX Therapeutics
CTMX
CTMX
97 hedge funds and large institutions have $79.5M invested in CytomX Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 40
Holders
97
Holding in Top 10
–
Calls
$37K
Puts
–
Top Buyers
| 1 | +$2.33M | |
| 2 | +$1.96M | |
| 3 | +$1.93M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.75M |
| 5 |
Renaissance Technologies
New York
|
+$1.02M |
Top Sellers
| 1 | -$5.79M | |
| 2 | -$5.36M | |
| 3 | -$3.45M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.97M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.78M |